These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10798741)

  • 41. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H; Wu J; Xu D; Luo H; Daloze PM
    Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
    Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance.
    Walpoth B; Galdikas J; Tschopp A; Lazeyras F; Altermatt HJ; Schaffner T; Althaus U; Billingham M; Morris R
    Transpl Int; 1992; 5 Suppl 1():S561-3. PubMed ID: 14621877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus.
    Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem Y
    Am J Transplant; 2004 Sep; 4(9):1514-22. PubMed ID: 15307840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
    Dong Y; Huang YF; Wang LQ; Chen B
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats.
    Sun Y; Chen X; Zhao J; Zou X; Li G; Li X; Shen B; Sun S
    Transpl Immunol; 2012 Aug; 27(1):19-24. PubMed ID: 22538197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 50. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse.
    Chen H; Qi S; Xu D; Vu DM; Fitzsimmons WE; Bekersky I; Peets J; Sehgal SN; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1039-41. PubMed ID: 9636419
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U; Paczek L; Mucha K; Foroncewicz B; Perkowska-Ptasińska A
    Transplant Proc; 2006; 38(1):66-8. PubMed ID: 16504666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
    Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
    Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapamycin in patients with chronic renal allograft dysfunction.
    Wu MS; Chang CT; Hung CC
    Clin Transplant; 2005 Apr; 19(2):236-42. PubMed ID: 15740561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys.
    Chen G; Sun H; Arp J; Garcia B; Wang X; Wise Y; Liu W; Ramcharran S; Huang X; Xiang Y; Yang H; Fang Z; Madrenas J; Sudo Y; Tamura K; Zhong R
    Am J Transplant; 2006 Apr; 6(4):714-23. PubMed ID: 16539628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
    Salazar A; McAlister VC; Kiberd BA; Bitter-Suermann H; Al-Kerithy MF; MacDonald AS
    Transplant Proc; 2001; 33(1-2):1038-9. PubMed ID: 11267181
    [No Abstract]   [Full Text] [Related]  

  • 59. Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.
    Cicora F; Roberti J; Vasquez D; Guerrieri D; Lausada N; Cicora P; Palti G; Chuluyan E; Gonzalez P; Stringa P; Raimondi C
    Clin Exp Immunol; 2012 Jan; 167(1):169-77. PubMed ID: 22132896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys.
    Kinugasa F; Nagatomi I; Ishikawa H; Nakanishi T; Maeda M; Hirose J; Fukahori H; Ooshima S; Noto T; Higashi Y; Seki N; Mutoh S
    J Pharmacol Sci; 2008 Dec; 108(4):529-34. PubMed ID: 19098392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.